FysioNord ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.5% 6.2% 5.8% 15.0% 8.3%  
Credit score (0-100)  38 38 38 13 28  
Credit rating  BBB BBB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  694 752 884 800 1,200  
EBITDA  29.2 35.9 18.7 -134 186  
EBIT  21.3 25.3 8.2 -145 176  
Pre-tax profit (PTP)  15.6 24.2 6.2 -144.3 174.7  
Net earnings  11.3 18.5 5.4 -112.7 133.0  
Pre-tax profit without non-rec. items  15.6 24.2 6.2 -144 175  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  44.8 34.2 23.7 13.2 2.6  
Shareholders equity total  61.3 79.8 85.2 -27.5 105  
Interest-bearing liabilities  122 12.0 12.0 0.0 109  
Balance sheet total (assets)  305 281 441 215 371  

Net Debt  21.6 -99.3 -140 -69.4 -5.7  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  694 752 884 800 1,200  
Gross profit growth  0.0% 8.4% 17.6% -9.5% 50.0%  
Employees  2 3 3 2 2  
Employee growth %  0.0% 50.0% 0.0% -33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  305 281 441 215 371  
Balance sheet change%  0.0% -7.8% 56.8% -51.2% 72.4%  
Added value  29.2 35.9 18.7 -134.4 186.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  37 -21 -21 -21 -21  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  3.1% 3.4% 0.9% -18.1% 14.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  7.3% 8.8% 2.3% -41.9% 57.3%  
ROI %  12.1% 18.4% 8.1% -274.9% 163.8%  
ROE %  18.4% 26.3% 6.5% -75.1% 83.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  20.1% 28.4% 32.8% -11.3% 28.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  73.9% -276.9% -749.6% 51.6% -3.0%  
Gearing %  199.3% 15.0% 14.1% 0.0% 103.1%  
Net interest  0 0 0 0 0  
Financing costs %  11.1% 2.7% 16.4% 17.0% 2.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.0 1.1 2.3 0.7 0.9  
Current Ratio  1.0 1.1 1.1 0.7 0.9  
Cash and cash equivalent  100.5 111.3 152.2 69.4 114.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -9.6 25.1 41.5 -67.7 -32.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  15 12 6 -67 93  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  15 12 6 -67 93  
EBIT / employee  11 8 3 -72 88  
Net earnings / employee  6 6 2 -56 66